Use of rocaglamide derivatives as NF-AT-specific inhibitors for the treatment of certain inflammatory diseases

摘要

Disclosed is the use of a rocaglarnide derivative of the formula (I) for the manufacture of a medicament which contains a rocaglamide derivative of formula (I) for the treatment of NF-AT-dependent inflammatory diseases, pharmaceutical compositions comprising rocaglamide derivatives and methods of producing such pharmaceutical compositions.